rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rhonda Lynette Hellums

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Silence Therapeutics; Chief Financial Officer, Aratana Therapeutics.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
0
First trade
1 Feb 2019
Last trade
2 Jan 2026
Last filed
6 Jan 2026

Companies traded

Where they are an officer
SLN Silence TherapeuticsDirector, Officer · Biotechnology · last 2 Jan 20260 buys · 0 sells
Aratana TherapeuticsOfficer · last 18 Jul 20190 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 6 Jan 2026SLN Silence Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—375,000 at $0.00filing
2 Jan 2026filed 6 Jan 2026SLN Silence Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—375,000 at $0.00filing
2 Jan 2025filed 6 Jan 2025SLN Silence Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—375,000 at $0.00filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—25,000filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—2,650filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—6,700filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—4,100filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—14,700filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—15,100filing
18 Jul 2019filed 18 Jul 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code D—67,527filing
18 Jul 2019filed 18 Jul 2019Aratana TherapeuticsSEC FORM 4 Code D—51,424filing
1 Feb 2019filed 5 Feb 2019Aratana Therapeuticsoption or derivativeSEC FORM 4 Code A—67,527 at $0.00filing
1 Feb 2019filed 5 Feb 2019Aratana TherapeuticsSEC FORM 4 Code A—24,923 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Richard Ian Griffiths10% owner · 10% owner at Silence Therapeutics, filing Form 4 there in the last year
Timothy McInerneyDirector · Director at Silence Therapeutics, filing Form 4 there in the last year
Steven J. RomanoDirector · EVP and Chief R&D Officer at Silence Therapeutics, filing Form 4 there in the last year
David LemusDirector · Director at Silence Therapeutics, filing Form 4 there in the last year
James Ede-GolightlyDirector · Director at Silence Therapeutics, filing Form 4 there in the last year